As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.

NPR's Rob Stein explains why covering vaccines is no longer routine science journalism, but a political battleground.

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Testing in mice suggests that rejuvenating T cells could make vaccines and some cancer therapies more effective.

Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...

The co-founder of SCIMaP looks at the year of NIH cuts — and what they say about the future of American research.

Bird flu, particularly H5N1, is spreading through animals, raising pandemic concerns. While human infections are rare and ...

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...

The death toll and economic damage associated with flu highlight its role as one of the most harmful viruses in history.

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.